Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 11/15/2025

Management of Polymicrobial CAUTI with Enterococcus faecalis and Staphylococcus aureus

Immediate Management Steps

  • Replace the indwelling catheter before starting antibiotics if it has been in place for ≥2 weeks, as this hastens symptom resolution and reduces risk of subsequent infection by removing the biofilm-laden device 1, 2
  • Obtain the urine culture specimen from the freshly placed catheter prior to initiating therapy, as the catheter biofilm may harbor organisms not accurately reflected in cultures from the old catheter 3
  • Remove the catheter entirely as soon as it is no longer clinically needed, as catheterization duration is the most important risk factor for CAUTI development 1, 2

Empirical Antibiotic Selection

  • For patients requiring parenteral therapy, intravenous third-generation cephalosporin (e.g., ceftriaxone) PLUS vancomycin to cover both Enterococcus faecalis and potential methicillin-resistant Staphylococcus aureus (MRSA), as multi-drug resistance is significantly higher in CAUTI 2
  • Alternative: Ampicillin/sulbactam provides coverage for both organisms and is recommended by European guidelines for complicated UTIs 2
  • For patients with mild-moderate symptoms who can tolerate oral therapy, Amoxicillin-clavulanate may provide adequate coverage for susceptible strains of both organisms, though this should be considered only after susceptibility confirmation 1, 2

Critical Considerations for Antibiotic Selection

  • Do NOT use fluoroquinolones (including levofloxacin) as monotherapy for this polymicrobial infection, as they provide inadequate coverage for Enterococcus species 1, 3
  • Do NOT use nitrofurantoin for CAUTI, as it doesn't achieve adequate serum concentrations to treat potential systemic infection 1
  • Base empirical therapy on local antimicrobial resistance patterns, as CAUTI organisms have higher resistance rates than community-acquired UTI pathogens 1, 2

Treatment Duration

  • 7 days of treatment if symptoms resolve promptly, regardless of whether the catheter remains in place 1, 2, 3
  • 10-14 days for patients with delayed clinical response or if systemic symptoms are present 1, 2, 3

Common Pitfalls to Avoid

  • Do NOT treat asymptomatic bacteriuria in catheterized patients, as this leads to antimicrobial resistance without clinical benefit 1, 4, 5
  • Do NOT delay catheter replacement if it has been in place for ≥2 weeks, as biofilm formation on the catheter protects organisms from antimicrobials 1, 5, 6
  • Do NOT use prophylactic antimicrobials at the time of catheter placement, removal, or routine replacement 5, 7